Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Ballard

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Bioorganic & Medicinal Chemistry Letters|December 8, 2006
Design, synthesis, and evaluation of efflux substrate-metal chelator conjugates as potential antimicrobial agentsYanling Zhang, C Eric Ballard, Shi-Long Zheng, et al.
The Journal of Biological Chemistry|February 12, 2013
γ-Secretase modulator (GSM) photoaffinity probes reveal distinct allosteric binding sites on presenilinNikolay Pozdnyakov, Heather E Murrey, Christina J Crump, et al.
Bioconjugate Chemistry|May 22, 2016
Determination of Antibody-Drug Conjugate Released Payload Species Using Directed in Vitro Assays and Mass Spectrometric InterrogationAndrew J Bessire, T Eric Ballard, Manoj Charati, et al.
Journal of the American Chemical Society|August 14, 2015
Systematic Evaluation of Bioorthogonal Reactions in Live Cells with Clickable HaloTag Ligands: Implications for Intracellular ImagingHeather E Murrey, Joshua C Judkins, Christopher W Am Ende, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2012
Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection modelCirle A Warren, Edward van Opstal, T Eric Ballard, et al.
Journal of Medicinal Chemistry|September 28, 2023
The Importance of Tracking "Missing" Metabolites: How and Why?Shuai Wang, T Eric Ballard, Lisa J Christopher, et al.
Drug Metabolism and Pharmacokinetics|January 6, 2026
Future directions in drug-drug interaction evaluations: Industry perspective on the ICH M12 guidanceKenichi Umehara, Andrew Harrell, Chandra Prakash, et al.
Bioconjugate Chemistry|December 14, 2018
Natural Product Bis-Intercalator Depsipeptides as a New Class of Payloads for Antibody-Drug ConjugatesAnokha S Ratnayake, Li-Ping Chang, L Nathan Tumey, et al.
Journal of Medicinal Chemistry|March 14, 2017
Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFRSimon Planken, Douglas C Behenna, Sajiv K Nair, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Bioorganic & Medicinal Chemistry Letters|December 8, 2006
Design, synthesis, and evaluation of efflux substrate-metal chelator conjugates as potential antimicrobial agentsYanling Zhang, C Eric Ballard, Shi-Long Zheng, et al.
The Journal of Biological Chemistry|February 12, 2013
γ-Secretase modulator (GSM) photoaffinity probes reveal distinct allosteric binding sites on presenilinNikolay Pozdnyakov, Heather E Murrey, Christina J Crump, et al.
Bioconjugate Chemistry|May 22, 2016
Determination of Antibody-Drug Conjugate Released Payload Species Using Directed in Vitro Assays and Mass Spectrometric InterrogationAndrew J Bessire, T Eric Ballard, Manoj Charati, et al.
Journal of the American Chemical Society|August 14, 2015
Systematic Evaluation of Bioorthogonal Reactions in Live Cells with Clickable HaloTag Ligands: Implications for Intracellular ImagingHeather E Murrey, Joshua C Judkins, Christopher W Am Ende, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2012
Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection modelCirle A Warren, Edward van Opstal, T Eric Ballard, et al.
Journal of Medicinal Chemistry|September 28, 2023
The Importance of Tracking "Missing" Metabolites: How and Why?Shuai Wang, T Eric Ballard, Lisa J Christopher, et al.
Drug Metabolism and Pharmacokinetics|January 6, 2026
Future directions in drug-drug interaction evaluations: Industry perspective on the ICH M12 guidanceKenichi Umehara, Andrew Harrell, Chandra Prakash, et al.
Bioconjugate Chemistry|December 14, 2018
Natural Product Bis-Intercalator Depsipeptides as a New Class of Payloads for Antibody-Drug ConjugatesAnokha S Ratnayake, Li-Ping Chang, L Nathan Tumey, et al.
Journal of Medicinal Chemistry|March 14, 2017
Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFRSimon Planken, Douglas C Behenna, Sajiv K Nair, et al.
Pageof 4